PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

PeerView
  • 4.0 (10)
  • SCIENCE

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

  1. 11H AGO

    Lauren A. Byers, MD - The ADC Wave in SCLC: Emerging Evidence and Practical Considerations for New Options on the Horizon

    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/XYC865. CME/MOC/AAPA credit will be available until January 29, 2027. The ADC Wave in SCLC: Emerging Evidence and Practical Considerations for New Options on the Horizon In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported through independent educational grants from Daiichi Sankyo, Inc., and Merck & Co., Inc., Rahway, NJ, USA. Disclosure information is available at the beginning of the video presentation.

    27 min

  2. 11H AGO

    Prof. Kevin J. Harrington, FCRP, FRCR, FRSB, PhD / Prof. Christophe Le Tourneau, MD, PhD - Staying Current on Immunotherapy for HNSCC: Conversations on Clinical Collaboration and Treatment Selection

    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/BGV865. CME credit will be available until February 11, 2027. Staying Current on Immunotherapy for HNSCC: Conversations on Clinical Collaboration and Treatment Selection In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. Disclosure information is available at the beginning of the video presentation.

    37 min

  3. 11H AGO

    Simron Singh, MD, MPH - Catalysts for Enhanced Patient CARE In Neuroendocrine Neoplasms: Clinical Adoption of Rapidly Emerging Evidence on Novel Therapeutic Strategies

    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JDA865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 8, 2027. Catalysts for Enhanced Patient CARE In Neuroendocrine Neoplasms: Clinical Adoption of Rapidly Emerging Evidence on Novel Therapeutic Strategies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Neuroendocrine Cancer Awareness Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This educational activity is supported by independent medical education grants from Boehringer Ingelheim Pharmaceuticals, Inc., Exelixis, Inc., and Novartis Pharmaceuticals Corporation. Disclosure information is available at the beginning of the video presentation.

    1h 18m

  4. 5D AGO

    Brooke Looney, PharmD, CSP / Alicia K. Morgans, MD, MPH, FASCO - Paving the Path for Optimal Prostate Cancer Care: Preparing Advanced Practice Providers to Integrate Modern Therapies Into Tailored Treatment Plans

    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/DBK865. CME/NCPD/CPE/AAPA/IPCE credit will be available until February 8, 2027. Paving the Path for Optimal Prostate Cancer Care: Preparing Advanced Practice Providers to Integrate Modern Therapies Into Tailored Treatment Plans In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by educational grants from Astellas and Pfizer, Inc. Disclosure information is available at the beginning of the video presentation.

    49 min

  5. 5D AGO

    Prof. Dr. Peter R. Galle - Streamlining Multidirectional Care in HCC: Applying Groundbreaking Evidence on Systemic Treatment Approaches Across the Disease Spectrum

    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FRD865. CME/MOC/AAPA/IPCE credit will be available until February 8, 2027. Streamlining Multidirectional Care in HCC: Applying Groundbreaking Evidence on Systemic Treatment Approaches Across the Disease Spectrum In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Blue Faery: The Adrienne Wilson Liver Cancer Association. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, Eisai Inc., and Merck & Co., Inc., Rahway, NJ, USA. Disclosure information is available at the beginning of the video presentation.

    1h 33m

  6. FEB 4

    Jaume Capdevila, MD, PhD - From Poor Prognosis to Emerging Clinical Potential: A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas

    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/PBT865. EBAC/CME credit will be available until 7 January 2027. From Poor Prognosis to Emerging Clinical Potential: A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. Disclosure information is available at the beginning of the video presentation.

    33 min

  7. FEB 4

    Nicole Lamanna, MD, Lydia Scarfò, MD - Choices, Changes, and Global Perspectives in CLL Care: Real-World Insights and New Evidence on Finite Therapy With Targeted Agents

    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAH/AAPA information, and to apply for credit, please visit us at PeerView.com/WBT865. CME/EBAH/AAPA credit will be available until January 25, 2027. Choices, Changes, and Global Perspectives in CLL Care: Real-World Insights and New Evidence on Finite Therapy With Targeted Agents In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an independent educational grant from AstraZeneca. Disclosure information is available at the beginning of the video presentation.

    37 min

  8. FEB 4

    Sara A. Hurvitz, MD, FACP - Key Steps to Success With CDK4/6 Inhibition in Early Through Metastatic Breast Cancer: Stratification, Selection, Sequencing, and Specialty Management

    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CTJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 6, 2027. Key Steps to Success With CDK4/6 Inhibition in Early Through Metastatic Breast Cancer: Stratification, Selection, Sequencing, and Specialty Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation. Disclosure information is available at the beginning of the video presentation.

    1h 24m
See All (543)

Ratings & Reviews

4
out of 5
10 Ratings

About

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

Information

More From PeerView

You Might Also Like